Humoral determinants of immunity to pneumococcal infection

Trial Profile

Humoral determinants of immunity to pneumococcal infection

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Sep 2017

At a glance

  • Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine (Primary)
  • Indications Pneumonia; Streptococcal infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 Jan 2010 Actual end date (September 2006) added as reported by ClinicalTrials.gov.
    • 18 Feb 2009 Actual initiation date (Jan 2003) added as reported by ClinicalTrials.gov.
    • 13 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top